Literature DB >> 2476250

Comparison of efficacy, toxicity and pharmacokinetics of free adriamycin and adriamycin linked to oxidized dextran in rats.

Y Ueda, K Munechika, A Kikukawa, Y Kanoh, K Yamanouchi, K Yokoyama.   

Abstract

Adriamycin linked to oxidized dextran (ADM-OXD) via Schiff's base formation was compared with free adriamycin with regard to antitumor activity, acute toxicity and plasma pharmacokinetics in rats following i.v. administration. ADM-OXD showed higher activity against Walker carcinosarcoma 256 than free adriamycin. On the other hand, the acute toxicity of ADM-OXD was about three times less than that of free adriamycin. In contrast to free adriamycin, a very high plasma level of adriamycin was found after i.v. administration of ADM-OXD. The area under the plasma concentration curve with ADM-OXD was about 160-fold higher than with free adriamycin. Thus, the improvement of the therapeutic index in the case of ADM-OXD might be due to the difference in the disposition of ADM-OXD and free adriamycin in rats.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476250     DOI: 10.1248/cpb.37.1639

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  4 in total

1.  Therapeutics: Detective work on drug dosage.

Authors:  Richard M Crooks
Journal:  Nature       Date:  2014-01-09       Impact factor: 49.962

2.  Real-time, aptamer-based tracking of circulating therapeutic agents in living animals.

Authors:  Brian Scott Ferguson; David A Hoggarth; Dan Maliniak; Kyle Ploense; Ryan J White; Nick Woodward; Kuangwen Hsieh; Andrew J Bonham; Michael Eisenstein; Tod E Kippin; Kevin W Plaxco; Hyongsok Tom Soh
Journal:  Sci Transl Med       Date:  2013-11-27       Impact factor: 17.956

3.  Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD).

Authors:  S Danhauser-Riedl; E Hausmann; H D Schick; R Bender; H Dietzfelbinger; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1993 May-Aug       Impact factor: 3.850

4.  Fragmentation of Injectable Bioadhesive Hydrogels Affords Chemotherapeutic Macromolecules.

Authors:  Yuji Yamada; Joel P Schneider
Journal:  Biomacromolecules       Date:  2016-07-15       Impact factor: 6.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.